Literature DB >> 737094

Observations on intravenous administration of lignocaine in patients with myocardial infarction.

N P Campbell, J G Kelly, A A Adgey, D G McDevitt, J F Pantridge.   

Abstract

Lignocaine was administered intravenously to 36 patients with acute myocardial infarction. A bolus of 100 mg followed by an infusion of 2 mg/minute failed to maintain plasma levels above 2 microgram/ml. A bolus of 100 mg followed by 4 mg/minute also failed to maintain satisfactory plasma concentrations during the first hour of therapy. A bolus of 75 mg was combined with an infusion of 10 mg/minute for 20 minutes followed by 1.5 mg/minute. Satisfactory plasma concentrations during the first hour were observed in 94 per cent of the estimations. No important adverse side effects occurred during the infusion of 10 mg/minute.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737094      PMCID: PMC483581          DOI: 10.1136/hrt.40.12.1371

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  Blood flow in muscle groups and drug absorption.

Authors:  E F Evans; J D Proctor; M J Fratkin; J Velandia; A J Wasserman
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

2.  Lignocaine: a new technique for intravenous administration.

Authors:  R A Levy; Y Charuzi; W J Mandel
Journal:  Br Heart J       Date:  1977-09

Review 3.  The clinical pharmacology of lidocaine as an antiarrhythymic drug.

Authors:  K A Collinsworth; S M Kalman; D C Harrison
Journal:  Circulation       Date:  1974-12       Impact factor: 29.690

Review 4.  Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1972-05

5.  A safe method for rapidly achieving plasma concentration plateaus.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

6.  Effect of propranolol, procainamide, and lidocaine on ventricular automaticity and reentry in experimental myocardial infarction.

Authors:  O W Gamble; K Cohn
Journal:  Circulation       Date:  1972-09       Impact factor: 29.690

7.  Antiarrhythmic effectiveness of intramuscular lidocaine: influence of different injection sites.

Authors:  M L Schwartz; M B Meyer; B G Covino; R M Narang; V Sethi; A J Schwartz; P Kamp
Journal:  J Clin Pharmacol       Date:  1974 Feb-Mar       Impact factor: 3.126

8.  Use of lidocaine by continuous infusion.

Authors:  M M Bassan; S R Weinstein; W J Mandel
Journal:  Am Heart J       Date:  1974-03       Impact factor: 4.749

9.  Letter: Effect of lidocaine on "gating" mechanism.

Authors:  J S Geddes; S W Webb; A A Adgey
Journal:  Am Heart J       Date:  1974-08       Impact factor: 4.749

10.  Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration.

Authors:  D J Sheridan; L Crawford; M D Rawlins; D G Julian
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

View more
  2 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

Review 2.  Prophylactic lidocaine for myocardial infarction.

Authors:  Arturo J Martí-Carvajal; Daniel Simancas-Racines; Vidhu Anand; Shrikant Bangdiwala
Journal:  Cochrane Database Syst Rev       Date:  2015-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.